On August 10, 2021, Parker Waichman LLP won a critical argument on behalf of plaintiffs who filed lawsuits alleging Tasigna® (Nilotinib) caused severe harm, including peripheral vascular disease, arterial damage necessitating surgical amputation of limbs, cardiovascular disease, arteriosclerosis, and/or other injuries. Trial attorney … [Read more...] about Parker Waichman LLP Wins Key Tasigna MDL Argument